John R Basile Selected Research

John R Basile Research Topics

Disease

25	Neoplasms (Cancer) 06/2023 - 07/2003
11	Squamous Cell Carcinoma of Head and Neck 08/2021 - 06/2006
7	Neoplasm Metastasis (Metastasis) 08/2021 - 06/2006
6	Carcinoma (Carcinomatosis) 12/2017 - 06/2006
3	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2017 - 08/2010
2	Melanoma (Melanoma, Malignant) 10/2019 - 01/2008
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2014 - 03/2013
2	Pathologic Neovascularization 01/2014 - 06/2008
2	Hypoxia (Hypoxemia) 08/2012 - 11/2009
1	Cysts 05/2021
1	Periodontal Cyst 05/2021
1	Odontogenic Cysts (Keratocyst) 05/2021
1	Heart Arrest (Cardiac Arrest) 10/2019
1	Myocarditis (Carditis) 10/2019
1	Dyspnea (Shortness of Breath) 10/2019
1	Xanthomatosis (Xanthoma) 02/2018
1	Hyperlipidemias (Hyperlipidemia) 02/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2017
1	Lymphoma (Lymphomas) 01/2017
1	Pathologic Processes 01/2017
1	Mucocele 06/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Lymphadenitis (Adenitis) 08/2014
1	Type 2 Diabetes Mellitus (MODY) 03/2013
1	Carcinogenesis 03/2013
1	Edema (Dropsy) 05/2011
1	Anthrax 01/2008
1	Granular Cell Tumor 07/2003
1	Inflammation (Inflammations) 02/2003

Drug/Important Bio-Agent (IBA)

13	CD100 antigenIBA 08/2021 - 06/2006
10	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 05/2011
5	Semaphorins (Semaphorin)IBA 01/2017 - 06/2008
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2012 - 06/2006
3	plexinIBA 01/2014 - 01/2011
3	Oxygen (Dioxygen)IBA 08/2012 - 06/2006
2	ParaffinIBA 05/2021 - 08/2014
2	Angiogenic ProteinsIBA 11/2017 - 01/2017
2	Interleukin-8 (Interleukin 8)IBA 01/2016 - 01/2011
2	AngiopoietinsIBA 05/2011 - 08/2010
1	Caspase 3 (Caspase-3)IBA 05/2021
1	NivolumabIBA 10/2019
1	IpilimumabIBA 10/2019
1	SteroidsIBA 10/2019
1	Immune Checkpoint InhibitorsIBA 10/2019
1	LipidsIBA 02/2018
1	GlycogenIBA 12/2017
1	Amylases FDA Link 12/2017
1	Coloring Agents (Dyes)IBA 12/2017
1	Angiopoietin-2IBA 11/2017
1	Adalimumab (Humira)FDA Link 02/2017
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	GTP Phosphohydrolases (GTPases)IBA 01/2017
1	MucinsIBA 06/2016
1	APTIBA 06/2016
1	Formaldehyde (Formol)FDA Link 08/2014
1	Calcium-Binding ProteinsIBA 08/2014
1	Annexin A2 (Annexin II)IBA 08/2014
1	EndoglinIBA 08/2014
1	SB 203580IBA 02/2014
1	MitogensIBA 02/2014
1	Phosphotransferases (Kinase)IBA 02/2014
1	p38 Mitogen-Activated Protein KinasesIBA 02/2014
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2014
1	Angiopoietin-Like Protein 4IBA 01/2014
1	cadherin 5IBA 01/2014
1	Antiviral Agents (Antivirals)IBA 05/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 03/2013
1	TOR Serine-Threonine KinasesIBA 03/2013
1	CarcinogensIBA 03/2013
1	AMP-Activated Protein KinasesIBA 03/2013
1	BiguanidesIBA 03/2013
1	Pharmacologic ActionsIBA 03/2013
1	Metformin (Glucophage)FDA LinkGeneric 03/2013
1	Blocking AntibodiesIBA 08/2012
1	Transcription Factors (Transcription Factor)IBA 08/2012
1	Neutralizing AntibodiesIBA 08/2012
1	rho-Associated KinasesIBA 01/2012
1	LigandsIBA 01/2012
1	CytokinesIBA 05/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2010
1	RNA (Ribonucleic Acid)IBA 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 11/2009
1	Virulence Factors (Pathogenicity Factors)IBA 01/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2008
1	Matrix Metalloproteinases (MMPs)IBA 01/2008
1	anthrax toxin receptorsIBA 01/2008
1	Metalloproteases (Metalloproteinases)IBA 03/2007
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 03/2007
1	AntibodiesIBA 06/2006
1	Small Interfering RNA (siRNA)IBA 06/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2003

Therapy/Procedure

6	Therapeutics 06/2023 - 07/2003
1	Defibrillators (Defibrillator) 10/2019
1	Immunotherapy 10/2019
1	Chemoprevention 03/2013
1	Radiotherapy 08/2012
1	Drug Therapy (Chemotherapy) 08/2012